Implementation Guide CH VACD
5.0.0 - trial-use
Implementation Guide CH VACD
5.0.0 - trial-use
This page is part of the CH VACD (R4) (v5.0.0: STU 5) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Generated Narrative: Organization TC-ORG-GSK
identifier: GLN/7601001000674
name: GlaxoSmithKline AG
telecom: ph: tel:+41 31 862 21 11(Work), fax: fax:+41 31 862 22 00(Work), mailto:swiss.info@gsk.com, https://www.gsk.com
address: Talstrasse 3-5 Münchenbuchsee BE 3053 CH